PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE TITLE PAIN MANAGEMENT GUIDELINE REFERENCE NUMBER TO BE CONFIRMED AFTER RATIFICATION MANAGER RESPONSIBLE Rosy Barnes - Acute Pain Clinical Nurse Specialist DATE ISSUED 14 June 2012 REVIEW DATE June 2014 Equality Impact Assessment has been applied to this policy Rosy Barnes - Acute Pain Clinical Nurse Specialist AUTHOR RATIFIED BY Rosy Barnes - Acute Pain Clinical Nurse Specialist Nursing and Midwifery Committee AMENDMENTS RECORD DATE PAGE(S) COMMENTS CONTENTS LIST: 1. 2. 3. 4. 5. 6. 7. 8. Introduction Status Purpose Scope/Audience Definitions Clinical Process Supporting Evidence Training APPENDICES: APPENDIX 1: Use of the Abbey Pain Scale APPENDIX 2: Paediatric Pain Tools FLACC and Wong and Baker APPENDIX 3: Inpatient referrals to the Chronic Pain Service APPENDIX 4: Palliative Care referral tool APPENDIX 5: Basic analgesia competency PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) APPROVED BY PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE 1. Introduction/Background Most patients experience pain or discomfort. The presence of pain causes distress and anxiety for patients. Managing patient’s pain is vitally important and Portsmouth Hospital NHS Trust considers that pain should be monitored and managed as the 5th vital sign. PHT believes that it is the right of all patients to receive adequate and appropriate pain relief. 2. Status This is a corporate clinical guideline 3. Purpose The relief of pain and discomfort should be a fundamental objective of any health service. Accurate assessment of patient’s pain and appropriate intervention reduces the risk of pain limiting an individual’s daily function. Good management reduces post-op complications and facilitates early or timely discharge. This guideline describes the standards of care to be provided to Portsmouth Hospitals NHS Trust patients experiencing pain or discomfort. 4. Scope / Audience This guideline applies to all staff involved in the direct care of patients. It is intended to be used in conjunction with specialized guidelines provided by The Acute, Chronic Pain and End of Life and Palliative care services. It is used for guidance only and is not ‘set in stone’. 5. Definitions Pain “An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage.” International Association for the Study of Pain (IASP) Acute pain Pain associated with acute injury or disease Chronic Pain Pain that has persisted for longer then 3 months or past the expected time of healing following injury or disease. Palliative Care Palliative care is the active total care of patients and their families, usually when their disease is no longer responsive to potentially curative treatment, although it may be applicable earlier in the illness. Pain Management Pain management is a multidisciplinary approach to the assessment and treatment of patients with pain. (Pain Management Services: The Royal College of Anaesthetists and the Pain Society) Health Care Professionals Registered Practitioners Band 5 – 9 Non-registered Practitioners Practitioners Band 2 - 4 Wessex Pain Score 0 = no pain at rest or on movement 1 = no pain at rest, mild pain on movement 2 = moderate pain at rest or on movement 3 = severe pain at rest 6. Clinical Process The provision of pain management for patients in PHT is underpinned by the following principles: PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE Pain management is the responsibility of all members of the multidisciplinary team. Pain will be anticipated wherever possible and appropriate prophylactic interventions applied e.g. for procedures. All patients will receive an initial and ongoing pain assessment as part of their treatment and care. All patients with pain will have evidence of pain management and a plan recorded in their notes. Pain presence will be recorded as the 5th vital sign. Pain intensity will be measured using the Wessex Pain Score (Verbal rating Score) and recorded on Vital Pac or the patients observation chart/record of care. (However some departments may use the verbal rating 1-10 score).This pain scale may not be appropriate for all patients, such as those with learning disabilities and/or dementia. In these cases the Abbey Pain Scale may be found to be more appropriate. (Appendix1). The FLACC and Wong and Baker Pain Scale are used for paediatrics. (Appendix 2) Patient with a pain intensity of 2 or 3 will trigger pain relief intervention. Pain will be reassessed and documented as part of each set of vital signs and: Within an appropriate time after pain relief intervention (i.e. when pain relief action is anticipated) After any procedure or activity anticipated being painful At intervals determined by ongoing chronic pain issues With each new report of pain Pain assessment, intervention and effectiveness will be documented. Ineffective pain relief will be documented and acted upon. Staff should be appropriately trained in the effective management of pain. (See training section 9) 6.1 Clinical Practice Guideline All health care professionals are responsible for: Assessment Planning Implementation of action plans Evaluation Clear documentation Liaison with all members of the multi-professional team All non-registered Practitioners Assess the patient using the Wessex or other appropriate pain score Report and document Liaise with all members of the multi-professional team Doctors, Dentists and Non medical Prescribers are responsible for: The prescribing of appropriate medication and regular review Provision of clear unambiguous prescription sheets (refer to Medicines Management Policy for completing prescription sheet) All Health Care Professionals have a role in the Initial and ongoing assessment of pain Provision of non-pharmacological pain relief intervention Administration of prescribed medication in a timely and non-judgemental fashion (HCSWs who have successfully completed the competency assessment for administration of medicines) Monitoring effect of medication Ensuring non registered practitioner given delegated tasks are competent to undertake said task Provisions of therapies and aids to support pain relief PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE Pharmacists are responsible for ensuring correct prescribing practice is adhered to and drugs prescribed are available within The District Formulary. For specialized areas of pain management, Portsmouth Hospitals NHS Trust provides an Acute Pain service, a Chronic Pain Service, End of Life and Palliative Care Service. The Acute Pain Team provides an inpatient service to the following areas: Surgical Unit, (including Head and Neck), Orthopaedic Unit, Renal/Urology and Gynaecology Unit Paediatrics and Maternity. Referrals may be made by phone on extension 5890 or via bleep 1645/1643 or 1838. The Department of Pain Medicine, serves patients with chronic pain on an outpatient basis only (Referral documentSee Appendix 3). The Hospital Specialist Palliative Care Team is a specialist service, working within the hospital. They work with those patients who have a life limiting illness and are experiencing difficulties (such as pain management) at any stage. (See referral form – Appendix 4) Guidance can also be obtained from the green ‘Palliative Care Handbook’, which should be available in all clinical areas. Contact details are extension 6132 0900-1700 Monday – Friday and out of hours The Rowans Hospice inpatient unit on 023 92 250001. The End of Life Team can be contacted on Bleep 1384 or mob - 07818078876 Pain should be assessed, documented and responded to regularly, and a record made of the patient’s response to treatment. 6.2 Process Pain can be managed by a variety of methods comprising pharmacological and non-pharmacological. Non-Pharmacological Interventions Non-pharmacological can be classified as cognitive behavioural approaches (education, relaxation, distraction) and physical agents (heat/cold, positioning, transcutaneous electrical nerve stimulation – TENS) Non-pharmacological methods must be considered to be an important element of pain relief. These include simple repositioning or ambulating when possible, application of hot or cold packs, distraction or relaxation techniques including deep breathing. Consideration should be given to referring to Physiotherapy. Approach Cognitive Behavioural Approach Effective in reducing mild to moderate pain and as an adjunct to analgesic drugs for severe pain. Intervention Jaw and Progressive muscle relaxation Use when patients express an interest in relaxation. Requires 2-3 minutes of staff time for instruction. Education/Instruction Provision of patient information leaflets, thorough, clear and concise explanations Simple imagery/Music Cutaneous Ice/Heat pads Effective in treating mild to TENS and acupuncture Should be applied with caution following assessment of the patient to ensure that there are no contradictions. Heat stimulates the thermoreceptors in the skin and deeper tissues that can reduce pain by closing the gating system in the spinal cord (Gate –Control theory). Cold will cause vasoconstriction and reduce swelling and should be applied (not directly to the skin) using ice packs or compresses. Needs specialized equipment and personnel to initiate PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE moderate pain and as an adjunct to analgesic drugs. Positioning treatment Elevation of limb Pharmacological Intervention Pharmacological methods range from simple oral medication to complex interventions including epidural infusions and patient controlled analgesia. The WHO analgesic ladder is a recognised systematic approach to the majority of pain problems. It is a statement of principles that can be used with a varying degree of interpretation, rather than a rigid framework. Regular analgesia should be given in timed intervals and on demand (PRN) analgesia should be given promptly when requested. Paediatrics: same principles, but drug doses depend on weight. (Refer to specific paediatric guidelines that can be found on the hospital intranet) The following examples refer to patients who have acute pain or are experiencing an acute episode of their chronic pain. In certain palliative care situations the green ‘Palliative Care Handbook’ should be used for guidance on developing a treatment plan. Below is a modified analgesic ladder for adults used in Portsmouth Hospitals NHS Trust for acute or an acute exacerbation of chronic pain. Chronic Pain, Non-Malignant Pain, Cancer Pain Step 1 Step 2 (Non-opioid (Weak opioids) analgesics/NSAIDS) Mild Pain (1) Paracetamol +/NSAID Non-pharmacological interventions Moderate Pain (2) Co-codamol (30/500) +/NSAID If unresponsive add Oral or Parenteral Opioids Non-pharmacological interventions Step 3 (Strong opioids, oral administration, transdermal patch, intravenous, subcutaneous, specialist local anaesthetic interventions) Severe Pain (3) Morphine 10-15mgs IM regularly or PCA or syringe driver if appropriate + NSAID +Paracetamol + Adjuncts Epidural, Neurolytic block therapy or spinal stimulation Acute Pain, Chronic Pain without control, acute crisis of Chronic Pain Paracetamol A maximum of 4 grams per day (8 500 mg tablets) Ensure patient is not already on a drug that contains Paracetamol (intravenous Paracetamol is available only for those patients unable to tolerate oral medication) Consider smaller doses if the patient weighs under 50kg for example 15mg/kg for under 50kg would be an appropriate dose. PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE Non Steroidal Anti-Inflammatory Drugs Ibuprofen (e.g. 400mg QDS) Diclofenac max 150mg per day (50mg TDS Oral/or PR) Use with caution. May cause GI upset/ulceration, renal failure and impaired clotting. May exacerbate symptoms in sensitive asthmatics (10%) Opioids Codydramol (paracetamol/dihydrocodeine) A maximum of 8 tablets per day Do not administer with Paracetamol Cocodamol (Paracetamol/codeine) A maximum of 8 tablets per day. Do not administer with Paracetamol. (2 strengths 30/500 and 8/500. The 8/500 is no more effective than Paracetamol but consider its use in the elderly, frail patient) Dihydrocodeine 30mg every 4-6 hours oral or IM Morphine Sulphate (Oral morphine solution) The bioavailability via the oral route is greatly decreased and the dosage when converting from IV/IM must be increased by a factor of 3 Morphine IV (rarely IM) 10-15 mg 2 hourly. Patient Controlled Analgesia (see PHNHST protocols http://pharmweb/publications/guidelines/Opioids%20IV%20in%20Postoperative%20Pain%20Management.pdf. IV bolus 2mg every 5 min. (10mg in 10ml N/Saline). Morphine SC 2.5 – 5 mg bolus (if opioid naive) Titrate to pain score and side effects Pethidine Morphine is preferred drug of choice Fentanyl/Alfentanyl May be appropriate in patients with poor renal function for PCA’s or syringe drivers Diamorphine IV or SC Oxycodone For use in patients with intolerable hallucinogenic side effects to morphine. Oxycontin® 10mg bd. Oxynorm® – 5mg 4 hourly oral prn for breakthrough pain. These are initial doses -that should be titrated to pain score and side effects Tramadol Produces analgesia by an opioid effect and an enhancement of serotonergic and adrenergic pathways. It is contraindicated in patients on warfarin or with epilepsy and should be used with caution in patients on SSRI’s, with poor renal function or low blood sodium Tapentadol Tapentadol is a new molecular entity that is structurally similar to tramadol. It has opioid and nonopioid activity in a single compound. Its general potency is somewhere between tramadol and morphine in effectiveness PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE This is only a limited guide to some analgesics that are available. Other adjunct drugs (ie tricyclic antidepressants, anticonvulsants) should also be considered. Entonox should also be considered as a stand alone or adjunct analgesic. (See Entonox policy http://www.porthosp.nhs.uk/Clinical-Policies/Entonox%20management.doc. Other supporting guidelines are: Naloxone for the treatment of opioid overdose in adults – http://pharmweb/publications/guidelines/Naloxone%20for%20the%20treatment%20of%20opioid%20overdose%20in% 20adults.pdf Controlled drugs management – http://www.porthosp.nhs.uk/Clinical-Policies/Controlled%20drugs%20management.doc Specialist local anaesthetic interventions These include continuous or single shot epidurals, regional blocks or other local anaesthetic interventions. They may be performed by the anaesthetist as part of a patient’s anaesthetic and post-operative management or in an outpatient clinic such as the Chronic Pain Clinic. http://pharmweb/publications/guidelines/Local%20Anaesthetic%20Infusions%20-%20Excluding%20Epidurals.pdf 6.3 Patients with Special Needs. Paediatrics/Neonates There are several categories of patients with special needs in pain management. Paediatrics and neonates, differ from adults in their response to drugs. Special care is needed in the neonatal period due to immature metabolic and excretory pathways (first 30 days of life) . Doses in this patient group invariably require calculations which should always be checked. Where possible, medicines for children should be prescribed within the terms of the product licence. However, many analgesics are not specifically licensed for paediatric use (See unlicensed medicines policy -. http://www.porthosp.nhs.uk/Clinical-Policies/Unlicensed Medicines use.doc Non-pharmacological interventions can be used with more success than perhaps in adults. Whenever possible, painful intramuscular injections should be avoided in children. The management of acute pain in children has been agreed at a multidisciplinary level (2005) under the umbrella of the Trust's Paediatric Clinical Governance Group which aims to ensure the highest standards of care for children undergoing surgery in Portsmouth and the recommendations and guidelines are available on the hospital intranet http://pharmweb/publications/guidelines/Analgesia%20Following%20Elective%20or%20Emergency%20Surgery%20i n%20Children.pdf. Other supporting guidelines are:The use of intranasal diamorphine in childrenhttp://pharmweb/publications/guidelines/Intranasal%20Diamorphine%20Administration%20to%20Children%20in%20t he%20Emergency%20Department.pdf The use of sucrose in neonates – http://pharmweb/publications/guidelines/Sucrose%20as%20Pain%20Relief%20and%20Pain%20Management%20in %20Neonates.pdf Older patients. The physiological, psychological and cultural changes associated with ageing affect the perception and reporting of pain by elderly patients. Older people are at particular risk of under or over treatment, increased sensitivity to the analgesic and side-effects of opioids and gastric and renal toxicity from Non-steroidal Anti-Inflammatory Drugs (NSAIDs) because of reduction in renal clearance and other pharmacokinetic changes associated with getting older. PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE Because elderly patients often receive multiple drugs for their multiple diseases this greatly increases the risk of drug interactions as well as adverse reactions and may affect compliance. If the patient has dementia the use of The Abbey Pain Scale may be more appropriate then the Wessex Pain Scale. Other supporting guidelines are:http://www.porthosp.nhs.uk/ClinicalGuidelines/Delirium%20diagnosis%20and%20management%20in%20Older%20People%20in%20a%20general%20h ospital%20setting.doc Opioid tolerant patients/substance misuse disorder Opioid tolerant patients are those with chronic cancer or non-cancer pain being treated with opioids or patients with a substance misuse disorder either using illicit opioids or an opioid maintenance treatment program. These patients can be complex to effectively manage their pain due to the presence of the drug (or drugs) of abuse, medications used to assist with drug withdrawal (ie buprenorphine) and the presence of tolerance, physical dependence and the risk of withdrawal. Opioid requirements are usually significantly higher in these patients. For the patient on prescription opioids their usual regimens should be maintained where possible or appropriate substitutions made. Effective analgesia may be required for longer periods and often requires a significant deviation from standard treatment protocols in the patient with a substance misuse disorder. Inappropriate behaviours can be prevented by the development of a respectful, honest and open approach to communication. If the patient is on a methadone program it should be continued as usual at the same dose and pain relief given for admission pain. Advice should be sought from the local substance misuse service where applicable. Palliative Care Accurate diagnosis of the cause(s) of pain is necessary for a rational approach to therapy. It must not be assumed that pain has been caused by the primary diagnosis; debility, previous treatment and unrelated causes must also be considered. All pains have significant psychological component, and fear, anxiety and depression will all lower the pain threshold. Remember also the likely effects of life changes associated with terminal disease including loss of financial security, altered body image and compromised sexual function. http://www.porthosp.nhs.uk/ClinicalGuidelines/Continuous%20Subcutaneous%20Infusion%20guideline%20Pan%20Trust.doc http://pharmweb/publications/guidelines/Medicines%20used%20in%20syringe%20drivers%20for%20palliative%20car e.pdf End of Life/Liverpool Care Pathway The LCP generic document guides and enables healthcare professionals to focus on care in the last hours or days of life. This provides high quality care tailored to the patient’s individual needs, when their death is expected. The recognition and diagnosis of dying is always complex, irrespective of previous diagnosis or history. Uncertainty is an integral part of dying. There are occasions when a patient who is thought to be dying lives longer than expected and vice versa. Seek a second opinion or specialist palliative care support as needed. http://pht/Departments/EndOfLifeCare/The%20Liverpool%20Care%20Pathway/Algorithms%20updated%20for%2012t h%20edition%20approved%20by%20education%20committee.doc Neuropathic Pain Neuropathic pain develops as a result of damage to, or dysfunction of, the system that normally signals pain. It may arise from a group of disorders that affect the peripheral and central nervous systems. Common examples include painful diabetic neuropathy, post-herpetic neuralgia and trigeminal neuralgia. People with neuropathic pain may experience altered pain sensation, areas of numbness or burning, and continuous or intermittent evoked or spontaneous pain. Neuropathic pain is an unpleasant sensory and emotional experience that can have a significant impact on a person's quality of life. Neuropathic pain is often difficult to treat, because it is resistant to many medications and/or because of the adverse effects associated with effective medications. A number of drugs are used to manage neuropathic pain, including antidepressants, anti-epileptic (anticonvulsant) drugs, opioids and topical treatments such as capsaicin and lidocaine. Many people require treatment with more than one drug, but the correct choice of drugs, and the optimal sequence for their use, has been unclear. PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE Supporting guidance: http://pharmweb/publications/guidelines/Peripheral%20Neuropathic%20Pain%20Management%20in%20Adults.pdf 7. Supporting Evidence Acute Pain Management: Scientific Evidence. 2010. Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. http://www.anzca.edu.au/resources/collegepublications/Acute%20Pain%20Management/books-and-publications/acutepain.pdf Best practice in the management of epidural analgesia in the hospital setting (2010). British Pain Society. http://www.britishpainsociety.org/pub_prof_EpiduralAnalgesia2010.pdf Cancer Pain Management (2010) http://www.britishpainsociety.org/book_cancer_pain.pdf Commission on the Provision of Surgical Services. Report of the Working Party on Pain After Surgery. London. Royal College of Surgeons of England and Royal College of Anaesthetists. 1990. Help the Aged - Pain in Older People: Reflections and Experiences from an older person's perspective (2008). http://www.britishpainsociety.org/book_pain_in_older_age_ID7826.pdf International Association for the study of Pain (IASP) www.iasp-pain.org/ Opioids for persistent pain: Good Practice (2010) British Pain Society http://www.britishpainsociety.org/book_opioid_main.pdf Pain Management Services. Good Practice. The Royal College of Anaesthetists and The Pain Society. May 2003. Recommendations for the appropriate use of opioids for persistent non-cancer pain. A consensus statement prepared on behalf of the pain Society, the Royal College of Anaesthetists, the Royal College of General Practitioners and the Royal College of Psychiatrists. March 2004. The Palliative Care Handbook. Advice on clinical management. 7 th edition. The Rowans Hospice. Portsmouth and Hampshire Specialist Palliative Care Team. http://pht/Departments/EndOfLifeCare/The%20Green%20Book/PC%20Handbook%207th%20Edition%20Oct%20201 0%20published.pdf The recognition and assessment of acute pain in Children (2009) http://www.rcn.org.uk/__data/assets/pdf_file/0004/269185/003542.pdf The use of drugs beyond licence in palliative care and pain management. A position statement prepared on behalf of the association for palliative medicine and the British pain Society. November 2005. http://www.britishpainsociety.org/book_usingdrugs_main.pdf 8. Training The Acute Pain Service provides training for all staff that work in the areas that are covered by the APS. This training comprises of compulsory attendance to the internal ‘Acute Pain Study Day’ run by the department and the completion of the relevant competency packs. To maintain competency a study day should be attended once every 3 years. PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE The Palliative Care Service provides external study days, updates and is available for informal teaching and advice (resource dependent). The green ‘Palliative Care Handbook’ is a useful resource tool to refer to. Training for Health Care Professionals in those areas not covered by the APS is the responsibility of the Modern Matrons, senior nurses and consultants and an “Analgesia competency is available to guide practice” (see Appendix 5). Appendix 1 Use of the Abbey Pain Scale The Abbey Pain Scale is best used as part of an overall pain management plan. The Pain Scale is an instrument designed to assist in the assessment of pain in patients who are unable to clearly articulate their needs. This could be due to their learning disabilities and/or dementia. This Pain Scale may not be appropriate for all patients with dementia or a learning disability. If further support is required regarding patients with a learning disability, please contact the Learning Disability Liaison Nurses on extension 5825 and in the interim use the Vital Pac 0-3 Smiley faces equivalent as below. The scale does not differentiate between distress and pain, so measuring the effectiveness of pain-relieving interventions is essential. It is recommended that the Abbey Pain Scale be used as a movementbased assessment. The staff recording the scale should therefore observe the patient while they are being moved, e.g. during pressure area care. Document corresponding 0-3 scale on vital Pac and ensure appropriate action is taken in response to results of assessment. A second evaluation should be conducted 1 hour after any intervention taken in response to the first assessment, to determine the effectiveness of any pain-relieving intervention and so forth until patient is recording scores of 0-1. PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE Use of the Abbey Pain Scale For measurement of pain in patients with dementia and/or learning disabilities who cannot verbalise. How to use the scale: While observing the patient, score questions 1 to 6. Q1. Vocalisation e.g. whimpering, groaning, crying Absent 0 Mild 1 Moderate 2 Severe 3 Q2. Facial Expression e.g. looking tense, frowning, grimacing, looking frightened Absent 0 Mild 1 Moderate 2 Severe 3 Q3. Change in body language e.g. fidgeting, rocking, guarding part of the body, withdrawn Absent 0 Mild 1 Moderate 2 Severe 3 Q4. Behavioural change e.g. increased confusion, refusing to eat, alteration in usual patterns Absent 0 Mild 1 Moderate 2 Severe 3 Q5. Physiological change e.g. temperature, pulse or blood pressure outside normal limits, perspiring, flushing or pallor Absent 0 Mild 1 Moderate 2 Severe 3 Q6. Physical changes e.g. skin tears, pressure areas, arthritis, contractures, and previous injury Absent 0 Mild 1 Moderate 2 Severe 3 Add scores for Q1 to Q6 together for total pain score = Now document on Vital Pac using corresponding 0 – 3 score PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE Abbey Score 0-2 3-7 8-13 14+ Vital Pac score 0 1 2 3 No pain Mild Moderate Severe Abbey J, De Bellis A, Piller N, Esterman A, Giles L, Parker D, Lowcay B. The Abbey Pain Scale. Funded by the JH and JD Medical Research Foundation 1998-2002 Appendix 2 FLACC Scale Category Scoring 1 2 3 Face No particular expression or smile Occasional grimace or frown, withdrawn, disinterested Frequent to constant quivering chin, clenched jaw Legs Normal position or relaxed Uneasy, restless, tense Kicking, or legs drawn up Activity Lying quietly, normal position, moves easily Squirming, shifting back and forth, tense Arched, rigid or jerking Cry No cry (awake or asleep) Moans or whimpers; occasional complaint Crying steadily, screams or sobs, frequent complaints Reassured by occasional touching, hugging or being talked to, distractible Difficult to console or comfort Consolability Content, relaxed Each of the five categories (F) Face; (L) Legs; (A) Activity; (C) Cry; (C) Consolability is scored from 0-2, which results in a total score between zero and ten. PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE Appendix 3 Please note-Incomplete forms will be returned to the referring doctor for completion. In Patient Referral Form to Chronic Pain Department Name: DOB: Hospital number: Date of referral: Estimated date of discharge: Ward -……………… Speciality-…………………………Consultant in charge……………………………………….. Referrer’s Name -…………………………………. Grade-…………………… Bleep -………………….. Alternative contact details- Name -…………………………………. Grade-…………………… Bleep …………… Diagnosis /Reason for admission ………………………………………………………………………………………………. Clinical details ……………………………………………………………………………………………………………… …………. ......…………………………………………………………………………………………………………… ……………………………………………………………………………………………………………… ……………………………………………………………………… Has the patient been diagnosed with a chronic pain Yes/No condition prior to this hospital admission? If yes what is the diagnosis? ………………………………………. Has the patient been treated for a chronic pain condition in the past? Yes, at the QAH /Yes, at a different hospital /No Was the patient on any analgesic or adjuvant pain medications prior to the current hospital admission? Please tick. Amitriptyline Gabapentin Pregabalin Morphine Buprenorphine Fentanyl Others………………………………………………. Please state reasons for referral? Acute flare up of the chronic pain problem. Acute pain unrelated to the chronic pain diagnosis Advice regarding analgesic and adjuvant medication titration For urgent interventional Pain procedure Other, Please specify- …… Please fax or deliver the completed form to the Acute Pain service in the department of Anaesthetics, E level, QAH. Fax no: 6681 for the attention of sister Rosy Barnes. For routine referrals as outpatients please contact chronic pain secretaries. Seen by APS: For inpatients visit For outpatient appointment: PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE REFERRAL POLICY: HOSPITAL SPECIALIST PALLIATIVE CARE TEAM Services offered by the Specialist Palliative Care Team A Multi-professional team of Consultant, and Clinical Nurse Specialists offering support and advice alongside hospital ward teams. The service is available to people with cancer and to those with nonmalignant disease, who would benefit from specialist palliative care, at any time from the point of diagnosis. Referral to the service can be made according to the following criteria: Those patients with persistent symptoms not responding to routine therapy. Those patients and their carers having difficulties in adjusting to their disease, including the need for psychologist assessment with high levels of depression and anxiety. Health care professionals who require specialist advice and support with case management. To assess the need for further specialist Inpatient care. How to refer: Referrals are accepted with patients’ consent, from hospital consultants and other staff acting on their behalf. Contact with the patient cannot be made until a written referral has been completed. However, telephone advice can be sought on 02392 286132 (0900-1700 Monday – Friday). Out of hours please contact The Rowans Hospice inpatient unit on Tel. No. 023 92 250001. All hospital referrals need to be faxed through to the Hospital Specialist Palliative Care Service, on the appropriate contact numbers below and a copy of the referral form needs to be retained in the patient’s notes, prior to contact with the patient. Standards for initial contact: Our aim is to see patients within 5 working days How to contact us: Hospital Specialist Palliative Care Team: Tel No: 023 92 286132 (Ext 6132) Working Hours: 0900-1700 (Monday-Friday) Fax No: 023 92 283332 (Ext 3332) PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE Telephone: 02392 286132 (Ext: 6132) Fax to: 02392 283332 REFERRAL FOR ASSESSMENT BY SPECIALIST PALLIATIVE CARE TEAM IN ORDER TO PRIORITISE PATIENT VISITS, PLEASE PROVIDE AS MUCH DETAILED INFORMATION AS POSSIBLE Referred By: (Full name & position) Has the patient consented to be seen by Date of Referral: the Specialist Palliative Care Team ? Extension No: Bleep No: YES NO Patient's name and Preferred Title: Home Address: Hospital No: NHS No: Date of Birth: Home Telephone No: WARD: GP: Address: Telephone No: DIAGNOSIS: EXTENT OF DISEASE: ANY OTHER SIGNIFICANT MEDICAL CONDITIONS Date of original diagnosis: WHAT HAS THE PATIENT BEEN TOLD-ABOUT: Current condition and likely prognosis REASONS FOR REFERRAL (MUST BE COMPLETED) Please give further details including current and failed management: (a) Persistent Symptoms (please give details) (b) Psychological Issues (please give details) (c) Support for Health Care Professional (please give details) (d) Assessment for Specialist In-patient Care (please give details) SOCIAL AND FAMILY SITUATION: Next of Kin: Ethnicity: PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) Religion: PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE Competency Statement: The Registered Nurse, Midwife or Practitioner will be competent in the administration of basic analgesia. Competency Indicators 1st Level a) Locate and discuss Trust policy with regards to drug administration. b) Identify and describe Wessex Pain Score and give rationale of use on ViEWS/MEOWS chart and admission documentation. c) Discuss and demonstrate general and specific monitoring of patients taking opioid analgesia, Paracetamol and NSAID’s. d) Discuss the causes of pain in relation to each patient you deal with and differentiate between local and referred pain. e) Demonstrate correct administration techniques include confirmation and checking of drug, patient route and rate. f) Demonstrate the ability to complete the prescription chart and completion of all appropriate paperwork. g) Demonstrate appropriate handover to personnel including, Nurses, Acute Pain Team, Medical Staff, Physiotherapists and Pharmacists. Competency Indicators 2nd Level Competency Indicators 3rd level Competency Indicators 4th level All of Level 1 plus: All of Levels 1 & 2 plus: All of Levels 1,2 & 3 plus: a) Discuss actions to be taken if analgesia is insufficient. b) Discuss how you would recognise an allergic reaction and an anaphylactic reaction and the action to be taken. c) Discuss the rationale for discontinuing specific analgesic drugs and the subsequent pain management plan. d) Discuss and demonstrate the procedure to be taken in the event of a drug error or adverse incident. e) Aware of alternative forms of pain-relieving techniques including positioning and distraction. a) Demonstrate the ability to the teach the Acute Pain Study Day with emphasis on ‘Drugs in the cupboard’. b) Lead the overall management of the Surgical Division patients on basic analgesia. c) Lead development of Clinical Guidelines and Policies. d) Carry out Audit. a) Discuss NMC Guidelines – ‘Standards for the Administration of Medicines’ and ‘The Scope of Professional Practice and ‘Code of Professional Conduct. b) Discuss the criteria for selection of analgesic and administration route. Identifying which routes would be appropriate for each patient. c) Discuss the actions, side effects, doses and potential complications for each drug prior to administration and how to deal with these complications. d) Ensure patients’ dignity is maintained during sensitive administration routes. e) Discuss and implement interventions (non drug) that may alleviate the patient’s pain. f) Discuss the resources PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE available (internal and external) that can be accessed for advice regarding analgesic drugs. Education resources to support Competency Achievement HCSW & St/N to attend Acute Pain Study Day. Attend study day every 3 years & update yearly via The Acute Pain Website Training Package. Registered Nurses to complete Drug Pack. The Pharmacology of Pain Control Session 8 Open Learning Programme for Health Care Workers. Stalker, N. Post Operative Analgesia. Anaesthetics Milner, Q. 2000 Author: Claire Wyman Department: Acute Pain Team Review Date: October 2013 Record of Achievement. To verify competence please ensure that you have the appropriate level signed as a record of your achievement in the boxes below. Level 1 Date: Level 2 Date: Level 3 Date: Level 4 Date: Signature of Educator/Trainer Signature of Educator/Trainer Signature of Educator/Trainer Signature of Educator/Trainer Date: Date: Date: Date: Signature of Workplace Assessor Signature of Workplace Assessor Signature of Workplace Assessor Signature of Workplace Assessor References to Support Competency PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE Acute Pain Study Day Lecture Booklet ‘Drugs in the Cupboard’ PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change) PORTSMOUTH HOSPITALS NHS TRUST CLINICAL GUIDELINE PHT Pain Management Guideline v1 Issued 14 June 2012 Review Date: June 2014 (unless requirements change)